Home
>
National Drug Code (NDC)
>
Cenestin
Cenestin - 51285-446-02 - (synthetic conjugated estrogens, A)
Drug Information of Cenestin
| Product NDC: | 51285-446 |
| Proprietary Name: | Cenestin |
| Non Proprietary Name: | synthetic conjugated estrogens, A |
| Active Ingredient(s): | .45 mg/1 & nbsp; synthetic conjugated estrogens, A |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cenestin
| Product NDC: | 51285-446 |
| Labeler Name: | Teva Women's Health Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020992 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041220 |
Package Information of Cenestin
| Package NDC: | 51285-446-02 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51285-446-02) |
NDC Information of Cenestin
| NDC Code | 51285-446-02 |
| Proprietary Name | Cenestin |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51285-446-02) |
| Product NDC | 51285-446 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | synthetic conjugated estrogens, A |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20041220 |
| Marketing Category Name | NDA |
| Labeler Name | Teva Women's Health Inc. |
| Substance Name | ESTROGENS, CONJUGATED SYNTHETIC A |
| Strength Number | .45 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
